HDAC Inhibitors as Novel Anti-Cancer Therapeutics

E-ISSN： 2212-3970|10|2|145-162

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.10, Iss.2, 2015-05, pp. : 145-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 7, 2015-01 ,pp. : 869-880

Bentham Science Publishers

Access to resources Recommend Favorite

Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 5, 2010-06 ,pp. : 354-370

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics

Current Cancer Therapy Reviews, Vol. 6, Iss. 4, 2010-11 ,pp. : 262-282

Bentham Science Publishers

Access to resources Recommend Favorite

Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 1, 2012-01 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Findings of Anti-cancer Property of Propofol

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 18, Iss. 2, 2018-04 ,pp. : 156-165

Bentham Science Publishers

Access to resources Recommend Favorite